Sleeplessness Relief

Manufacturer
Similasan Corporation
Effective date
2013-07-11
Label type
HUMAN OTC DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-06-01 02:04:58

Label at a glance#

ProductSleeplessness Relief
Active ingredientAVENA SATIVA FLOWERING TOP, CALCIUM SULFIDE, ANEMONE PATENS, ZINC VALERATE DIHYDRATE
Label structure15 sections

Indications and uses

Relieves symptoms of occasional sleeplessness and/or restless sleep - Difficulty in going to sleep and frequent waking during the night - Disturbed sleep due to inability "to switch off", tenseness and restlessness - Restless, light sleep and excessive dreaming 

Dosage and administration

For adults and children ages 2 and above: - Remove tamper-evident seal from neck of bottle. - Twist cap off bottle. - Dispense 7-10 globules, place in mouth and allow to dissolve.  Do not swallow globules. - Allow the globules to dissolve in the mouth. Occasional Sleeplessness: Take in the evening before going to bed. If you don't find relief immediately, repeat every fifteen minutes.  Also take during the night i...

Label contents#

Full prescribing information#

Active ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Avena sativa 12X

Purpose

OTC - PURPOSE SECTION

sleeplessness, nervousness

Active ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Hepar sulphuris 12X

Purpose

OTC - PURPOSE SECTION

restlessness

Active ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Pulsatilla 15X

Purpose

OTC - PURPOSE SECTION

irregular/agitated sleep

Active ingredient(s)

OTC - ACTIVE INGREDIENT SECTION

Zincum valerianicum 12X

Purpose

OTC - PURPOSE SECTION

sleeplessness

Uses:

INDICATIONS & USAGE SECTION

Relieves symptoms of occasional sleeplessness and/or restless sleep
- Difficulty in going to sleep and frequent waking during the night
- Disturbed sleep due to inability "to switch off", tenseness and restlessness
- Restless, light sleep and excessive dreaming 

Warnings:

WARNINGS SECTION

- Consult a physician before use if pregnant or breast feeding.
- Consult a physician if symptoms persist for more than 2 weeks or worsen.
- Keep this and all medications out of the reach of children.
- Do not use if tamper-evident seal is broken.
- In case of accidental overdose, get medical help or contact a Poison Control Center immediately.

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep this and all medications out of the reach of children

Directions:

DOSAGE & ADMINISTRATION SECTION

For adults and children ages 2 and above:
- Remove tamper-evident seal from neck of bottle.
- Twist cap off bottle.
- Dispense 7-10 globules, place in mouth and allow to dissolve.  Do not swallow globules.
- Allow the globules to dissolve in the mouth.

Occasional Sleeplessness: Take in the evening before going to bed. If you don't find relief immediately, repeat every fifteen minutes.  Also take during the night if you wake frequently.

Other information:

SPL UNCLASSIFIED SECTION

Active ingredients are microdiluted in accordance with the Homeopathic Pharmacopoeia of the United States, and are therefore non-toxic and have no known side effects.

Inactive ingredients:

INACTIVE INGREDIENT SECTION

Calcium carbonate, Xylitol (Sugar-free)

Questions?

OTC - QUESTIONS SECTION

Call 1-800-240-9780 for 24hr recorded product information. Representatives available, M-F, 8am-5pm (MT), or visit: www.SimilasanUSA.com

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 59262-601-30
Similasan
Sleeplessness Relief
Globules
15g/ 0.529 oz

Sleeplessness Relief BoxSleeplessness Relief Box

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59262-601-302020-01-31C16284748780-19d75b9d0-8464-f424-e053-dadaa90a57ceSleeplessness Relief

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59262-601-30Sleeplessness Relief1078 in 1 BOTTLE, GLASSGLOBULE10785

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59262-601SLEEPLESSNESS RELIEF (AVENA SATIVA AND HEPAR SULPHURIS AND PULSATILLA AND ZINCUM VALERIANICUM) GLOBULE [SIMILASAN CORPORATION]5Legacy NDC, 1 package rows20130920_6b94321a-1a0a-4e6e-b931-618df8688eb2.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59262-601-30GM - Gram59262-6015e082219-6906-49af-a314-ec29e4eb79b412016-06-14

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ANEMONE PATENSACTIVE INGREDIENT4M1169RWJD5
AVENA SATIVA FLOWERING TOPACTIVE INGREDIENTMA9CQJ3F7F5
CALCIUM SULFIDEACTIVE INGREDIENT1MBW07J51Q5
ZINC VALERATE DIHYDRATEACTIVE INGREDIENTMN0RX54EQA5
ANEMONE PATENSACTIVE MOIETY4M1169RWJD5
AVENA SATIVA FLOWERING TOPACTIVE MOIETYMA9CQJ3F7F5
CALCIUM SULFIDEACTIVE MOIETY1MBW07J51Q5
VALERIC ACIDACTIVE MOIETYGZK92PJM7B5
CALCIUM CARBONATEINACTIVE INGREDIENTH0G9379FGK5
XYLITOLINACTIVE INGREDIENTVCQ006KQ1E5

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59262-60159262-601-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 27 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKGUM, CHEWING / BUCCAL3492 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, DELAYED RELEASE / ORAL8.4 mgExact identifier — unii candidate
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1EFILM, SOLUBLE / ORAL29 mgExact identifier — unii candidate
12 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ETABLET / ORAL15.04 mgExact identifier — unii candidate
12 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESOLUTION / ORAL21600 mgExact identifier — unii candidate
12 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ETABLET, FILM COATED, EXTENDED RELEASE / ORAL72 mgExact identifier — unii candidate
12 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, EXTENDED RELEASE / ORAL229.7 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE, DELAYED RELEASE / ORAL20 mgExact identifier — unii candidate
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESUSPENSION, EXTENDED RELEASE / ORAL9000 mgExact identifier — unii candidate
12 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1EPASTE / ORAL180 mgExact identifier — unii candidate
12 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKFILM, SOLUBLE / ORAL14 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, FILM COATED / ORAL300 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKSOLUTION / AURICULAR (OTIC)0.38 %w/wExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE, EXTENDED RELEASE / ORAL4 mgExact identifier — unii candidate
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1EGUM, CHEWING / BUCCAL11915 mgExact identifier — unii candidate
12 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, COATED / ORAL64.8 mgExact identifier — unii candidate
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ETABLET, ORALLY DISINTEGRATING / ORAL360 mgExact identifier — unii candidate
12 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ETABLET, EXTENDED RELEASE / ORAL2752 mgExact identifier — unii candidate
12 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET, CHEWABLE / ORAL1650 mgExact identifier — unii candidate
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESPRAY / SUBLINGUAL22 mgExact identifier — unii candidate
12 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKTABLET / ORAL793 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKCAPSULE / ORAL349.9 mgExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKSOLUTION / RESPIRATORY (INHALATION)4.02 %w/vExact identifier — unii candidate
15 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKPOWDER, DENTIFRICE / DENTAL0.5 mg/mgExact identifier — unii candidate
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1ESUSPENSION / ORAL1500 mgExact identifier — unii candidate
12 equally ranked IID candidates
CALCIUM CARBONATECALCIUM CARBONATEH0G9379FGKSOLUTION / INTRAVENOUS4.02 %w/vExact identifier — unii candidate
15 equally ranked IID candidates
XYLITOLXYLITOLVCQ006KQ1EPOWDER, FOR SUSPENSION / ORAL4223 mgExact identifier — unii candidate
12 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
088190e0-6a24-4b6c-a72a-00bd79ae78956b94321a-1a0a-4e6e-b931-618df8688eb22013-07-11WarningsExact identifier
spl id: 088190e0-6a24-4b6c-a72a-00bd79ae7895
spl set id: 6b94321a-1a0a-4e6e-b931-618df8688eb2

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.